Applying gene expression microarrays to pulmonary disease

Respirology

Volumn 16, Issue 3, 2011, Pages 407-418

  Campbell, Joshua D ^a   Spira, Avrum ^a   Lenburg, Marc E ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Biomarker; Gene expression; Microarray; Pulmonary disease; Pulmonary medicine

Indexed keywords

4,5 DIANILINOPHTHALIMIDE; BIOLOGICAL MARKER; DNA; EARLY GROWTH RESPONSE FACTOR 1; FIBRONECTIN; INOSITOL; MATRILYSIN; MICRORNA; NOOTROPIC AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; RAS PROTEIN; RNA; UNCLASSIFIED DRUG;

AIRWAY REMODELING; CANCER DIAGNOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUSTER ANALYSIS; DISEASE CLASSIFICATION; DNA HYBRIDIZATION; DNA SEQUENCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME ANALYSIS; HUMAN; INFORMATION PROCESSING; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG DISEASE; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; RNA SEQUENCE; SEQUENCE ANALYSIS;

DRUG RESISTANCE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG DISEASES; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTEOMICS;

EID: 79953281038     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.01942.x     Document Type: Review

References (51)

1. Manolio T. Genomewide association studies and assessment of the risk of disease. N. Engl. J.Med. 2010; 363: 166-76.
2. Huang Y, Huang TH, Wang L. Profiling DNA methylomes from microarray to genome-scale sequencing. Technol. Cancer Res. Treat. 2010; 9: 139-47.
3. Emanuel BS, Saitta SC. From microscopes to microarrays: dissecting recurrent chromosomal rearrangements. Nat. Rev.Genet. 2007; 8: 869-83.
4. Collins FS, Morgan M, Patrinos A. The Human Genome Project: lessons from large-scale biology. Science 2003; 300: 286-90. (Pubitemid 36433711)
5. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921. (Pubitemid 32165345)
6. Quackenbush J.Microarray analysis and tumor classification. N. Engl. J.Med. 2006; 354: 2463-72.
7. Fan J, Ren Y. Statistical analysis ofDNAmicroarray data in cancer research. Clin. Cancer Res. 2006; 12: 4469-73.
8. Reimers M. Making informed choices about microarray data analysis. PLoS Comput. Biol. 2010; 6: e1000786.
9. Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003; 19: 368-75. (Pubitemid 36284936)
10. Golub TR, Slonim DK, Tamayo P et al.Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-7.
11. Li L, Weinberg CR, Darden TA et al. Gene selection for sample classification based on gene expression data: study of sensitivity to choice of parameters of the GA/KNN method. Bioinformatics 2001; 17: 1131-42. (Pubitemid 33735339)
12. Zhang H, Yu C, Singer B. Cell and tumor classification using gene expression data: construction of forests. Proc. Natl. Acad. Sci. U.S.A. 2003; 100: 4168-72.
13. Khan J, Wei JS, Ringnér M et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat.Med. 2001; 7: 673-9. (Pubitemid 32588022)
14. Furey TS, Cristianini N, Duffy N et al. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 2000; 16: 906-14.
15. D'haeseleer P. How does gene expression clustering work? Nat. Biotechnol. 2005; 23: 1499-501.
16. Hayes DN,Monti S, Parmigiani G et al. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. J. Clin. Oncol. 2006; 24: 5079-90.
17. Kicic A, Hallstrand TS, Sutanto EN et al. Decreased fibronectin production significantly contributes to dysregulated repair of asthmatic epithelium. Am. J. Respir. Crit. Care Med. 2010; 181: 889-98.
18. Bhattacharya S, Srisuma S, Demeo DL et al. Molecular biomarkers for quantitative and discrete COPD phenotypes. Am. J. Respir. Cell Mol. Biol. 2009; 40: 359-67.
19. Spira A, Beane J, Pinto-Plata V et al. Gene expression profiling of human lung tissue from smokers with severe emphysema. Am. J. Respir. Cell Mol. Biol. 2004; 31: 601-10.
20. Wang IM, Stepaniants S, Boie Y et al. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am. J. Respir. Crit. Care Med. 2008; 177: 402-11.
21. Golpon HA, Coldren CD, Zamora MR et al. Emphysema lung tissue gene expression profiling. Am. J. Respir. Cell Mol. Biol. 2004; 31: 595-600.
22. Zeskind J, Lenburg ME, Spira A. Translating the COPD transcriptome: insights into pathogenesis and tools for clinical management. Proc. Am. Thorac. Soc. 2008; 5: 834-41.
23. Ning W, Li C, Kaminski N et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc.Natl. Acad. Sci. U.S.A. 2004; 101: 14895-900.
24. Yan SF, Pinsky DJ,MackmanNet al. Egr-1: is it always immediate and early? J. Clin. Invest. 2000; 105: 553-4.
25. Zhang W, Yan SD, Zhu A et al. Expression of Egr-1 in late stage emphysema. Am. J. Pathol. 2000; 157: 1311-20.
26. Takizawa H, Tanaka M, Takami K et al. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am. J. Respir. Crit. Care Med. 2001; 163: 1476-83.
27. Zhu YK, Liu X, Ertl RF et al. Retinoic acid attenuates cytokinedriven fibroblast degradation of extracellular matrix in threedimensional culture. Am. J. Respir. CellMol. Biol. 2001; 25: 620-7.
28. Zuo F, Kaminski N, Eugui E et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc. Natl. Acad. Sci. U.S.A. 2002; 99: 6292-7.
29. Steiling K, Ryan J, Brody JS et al. The field of tissue injury in the lung and airway. Cancer Prev. Res. (Phila) 2008; 1: 396-403.
30. Spira A, Beane J, Shah V et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc.Natl. Acad. Sci. U.S.A. 2004; 101: 10143-8.
31. Schembri F, Sridhar S, Perdomo C et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airwayepithelium.Proc.Natl. Acad.Sci.U.S.A. 2009; 106: 2319-24.
32. Steiling K, Kadar AY, Bergerat A et al. Comparison of proteomic and transcriptomic profiles in the bronchial airway epithelium of current and never smokers. PLoS ONE 2009; 4: e5043.
33. Spira A, Beane JE, Shah V et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat.Med. 2007; 13: 361-6. (Pubitemid 46376687)
34. Beane J, Sebastiani P, Whitfield TH et al. A prediction model for lung cancer diagnosis that integrates genomic and clinical features. Cancer Prev. Res. (Phila) 2008; 1: 56-64.
35. Bull TM, Coldren CD,MooreMet al. Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 2004; 170: 911-19.
36. Xi L, Lyons-Weiler J, Coello MC et al. Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas. Clin. Cancer Res. 2005; 11: 4128-35.
37. Chen H, Yu S, Chen C et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N. Engl. J. Med. 2007; 356: 11-20.
38. Shedden K, Taylor JM, Enkemann SA et al. Gene expressionbased survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat.Med. 2008; 14: 822-7.
39. Canales RD, Luo Y,Willey JC et al. Evaluation of DNA microarray results with quantitative gene expression platforms. Nat. Biotechnol. 2006; 24: 1115-22.
40. Shi L, Campbell G, Jones WD et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.Nat. Biotechnol. 2010; 28: 827-38.
41. Selman M, Pardo A, Barrera L et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 2006; 173: 188-98.
42. Bhattacharjee A, Richards WG, Staunton J et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. U.S.A. 2001; 98: 13790-5.
43. Bild AH, Yao G, Chang JT et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006; 439: 353-7. (Pubitemid 43128862)
44. Rodenhuis S, Boerrigter L, Top B et al. Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study. J. Clin. Oncol. 1997; 15: 285-91.
45. Gustafson AM, Soldi R, Anderlind C et al. Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci. Transl.Med. 2010; 2: 26ra25.
46. Lamb J, Crawford ED, Peck D et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006; 313: 1929-35. (Pubitemid 44497995)
47. Goleva E, Hauk PJ, Hall CF et al. Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J. Allergy Clin. Immunol. 2008; 122: 550-9.
48. Winter J, Jung S, Keller S et al.Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 2009; 11: 228-34.
49. Baker M. MicroRNA profiling: separating signal from noise. Nat. Methods 2010; 7: 687-92.
50. Pandit KV, Corcoran D, Yousef H et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2010; 182: 220-9.
51. Yanaihara N, Caplen N, Bowman E et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-98. (Pubitemid 43357945)